HOME >> BIOLOGY >> NEWS
Food preservative neutralizes anthrax spores

BALTIMORE, MD March 21, 2005 -- Nisin, a commonly used food preservative effectively neutralizes anthrax spores and could be used to decontaminate skin in the event of exposure. Researchers from Biosynexus, Inccorporated report their findings today at the 2005 American Society for Microbiology Biodefense Research Meeting.

"Contamination of human skin with even a few spores may potentially disseminate disease beyond the initial area of attack," says John Kokai-Kun, a researcher on the study. "There is currently nothing specifically approved for decontaminating human skin of anthrax spores."

Nisin is a natural antimicrobial peptide used as a preservative in heat-processed and low pH foods. It is derived from the controlled fermentation of the naturally occurring milk bacteria Lactococcus lactis. Nisin was awarded the Generally Regarded as Safe (GRAS) designation in the U.S. Federal Register of April, 1988 and is approved as a natural food preservative in the United States. It is also being used in the dairy industry as a topical treatment for mastitis.

Kokai-Kun and his colleagues tested the ability of nisin to neutralize spores of both anthrax and a related microbe, Bacillus cereus. Spores were pre-treated with nisin and then given variety of tests, including their ability to germinate and to cause disease in mice. While untreated spores in a control group were able to germinate and grow in culture and cause lethal infection in mice, the treated spores remained dormant and caused no apparent disease.

The next step for the researchers is to formulate a delivery system. One that appears to have promise is an impregnated wipe. A similar product, with a much lower concentration of nisin than would be necessary against anthrax is already available commercially for treating mastitis in cows. Other options include a topical cream or a foam.

"Given the capacity of nisin to neutralize spores, its common topical use on animals and its GRAS
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
21-Mar-2005


Page: 1 2

Related biology news :

1. Researchers from the UGR use a bacterium to obtain biopreservatives from food
2. Common food preservative might provide treatment for cystic fibrosis
3. Antibody that neutralizes most HIV strains described by scientists at The Scripps Research Institute
4. A treatment, not a cure: Calcium silicate neutralizes an acidic stream
5. Taming the anthrax threat
6. New finding points way to foiling anthraxs tricks
7. UGA researchers discover cell-wall carbohydrate that is crucial to anthrax bacterium
8. New anthrax inhibitor could combat antibiotic-resistant strains
9. Combating anthrax: Results of study published this month as researchers look for a better vaccine
10. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
11. Patent awarded for LSUHSC-developed peptide that blocks lethal toxins of anthrax

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... Md. (PRWEB) , ... March 29, 2019 , ... ... Stem/Stromal Cell (hMSC) biomanufacturing systems, will attend the Society for Biomaterials Annual Meeting ... gives us the opportunity to connect with academic, healthcare, governmental and business professionals ...
(Date:3/27/2019)... ... March 27, 2019 , ... ... been awarded the 2019 Global Health & Pharma Biotechnology Award as the Best ... & Pharma’s Biotechnology Awards honor individuals and companies whose accomplishments have proved evidence ...
(Date:3/25/2019)... ... March 25, 2019 , ... ... and research genetic testing, today announced a new laboratory services agreement with Clovis ... for cancer. Through this laboratory services agreement, Ambry Genetics and Clovis Oncology ...
Breaking Biology News(10 mins):
(Date:4/8/2019)... ... , ... US Capital Global Securities , an affiliate of US Capital ... privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline of drugs ... dysfunction disorder and is ready to begin phase 2b trials. In phase 2a trials, ...
(Date:3/27/2019)... ... March 26, 2019 , ... A leader in the field ... to veterinarians across the United States and Canada since 2004. The primary indications ... tissue injuries in the dog, cat, and horse. Recently, VetStem teamed up ...
(Date:3/19/2019)... ... , ... The AACR annual conference pulls together a diverse group of clinical ... research. The Visikol team will be at the show at booth #3252 and will ... their digital pathology services . “For AACR this year we are highlighting specifically ...
(Date:3/19/2019)... BASEL, Switzerland (PRWEB) , ... ... ... Center at Tel HaShomer, the largest hospital in Israel and the Middle ... cell-therapy manufacturing using the state-of-the-art Cocoon™ manufacturing platform. The partnership will enable ...
Breaking Biology Technology:
Cached News: